Desferrioxamine (DFO) used as a chelator in treatment of chronic iron over load diseases was evaluated for its effects on proteins and nucleic acid contents in hepatic cells of mice on acute and sub-acute treatment. The acute treatment of DFO failed to significantly affect the levels of proteins and nucleic acids in hepatic cells. However, on sub-acute administration for 7 days, DFO was found to reduce the levels of RNA and DNA compared to control. These changes were statistically insignificant, however, the results clearly indicated the weak cytotoxic potentials of DFO on sub-acute treatment.